Skip to content

Circles

C

Cardiff Oncology, Inc.

CRDF· Nasdaq

C

CRDFCardiff Oncology, Inc.

CRDFCardiff Oncology, Inc.·Earnings record

Q2 2011

Source filing unavailable

Previous · Q1 2011 Next · Q3 2011

Q2 2011 · —

Revenue

$79.86K

no prior Q2 2010 on file

Net Income

-$449.16K

no prior Q2 2010 on file

EPS Diluted

-$0.05

no prior Q2 2010 on file

Operating Income-$647,450—

Operating Cash Flowderived-$448,239—

Same quarter

no prior Q2 2010 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Filing lag

Quarterly history

Q1 ’11Q2 ’11Q3 ’11 Q4 ’11^d Q1 ’12 Q2 ’12 Q3 ’12 Q4 ’12 Q1 ’13…

Cardiff Oncology, Inc. · CIK 1213037 · Engraved from SEC EDGAR

Free Cash Flowderived

-$448,240—

Margins · derived

Operating margin-810.7%

Net margin-562.4%

Thaler ResearchEngraved from SEC EDGAR© 2026 Thaler. All rights reserved.Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Platform

Using AI API SDKs CLI

Research

News Listen Earnings Movers Indexes IPOs Insiders Holders Compare Metrics

Screener Watchlists Pies Notes Your companies

Learn

Thaler

Thaler Agent Promise Provenance Changelog Circles Account Terms Privacy